Suppr超能文献

通过氨基葡萄糖还原法制备等离子体银纳米颗粒:应用于比色传感器测定其药物制剂中的氨基葡萄糖。

Formation of plasmonic silver nanoparticles by glucosamine reduction: Application to a colorimetric sensor for determination of glucosamine in its pharmaceutical preparations.

作者信息

Abdel Hamid Mohamed, Habib Ahmed, Mabrouk Mokhtar, Hammad Sherin, Elshahawy Mahmoud

机构信息

Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

出版信息

J Pharm Biomed Anal. 2023 Nov 30;236:115705. doi: 10.1016/j.jpba.2023.115705. Epub 2023 Sep 8.

Abstract

The purpose of this study is to develop a novel method for synthesizing silver nanoparticles using glucosamine as reducing agent and to utilize the developed method for colorimetric detection and quantitative determination of the non-chromophoric drug, glucosamine. Silver nanoparticles are prepared by reducing 0.02 mol/L silver nitrate by glucosamine in 0.075 mol/L ammonia and stabilizing the nanoparticles with 0.1% polyvinylpyrrolidone and the mixture is heated at 90 °C for 5 min. The prepared silver nanoparticles dispersed in water exhibit a bright yellow color due to a localized surface plasmon resonance band at 412 nm. The principle of glucosamine sensing is based on measuring the intensity of the surface plasmon resonance band at 412 nm which is directly proportional to the concentration of glucosamine with a linearity range (1 - 9 μg/mL), limit of detection 0.33 μg/mL and limit of quantitation 1.0 μg/mL. The proposed method was validated according to the ICH guidelines, and it was found to be accurate, precise, selective, and robust. The method was applied for determination of glucosamine in Joflex® capsules using the standard addition approach with mean % recovery ± standard deviation of 100.077 ± 1.786. The method is simple, rapid, and cost-effective and can be used for determination of glucosamine in bulk and in its pharmaceutical preparations.

摘要

本研究的目的是开发一种以氨基葡萄糖为还原剂合成银纳米颗粒的新方法,并利用所开发的方法对非发色药物氨基葡萄糖进行比色检测和定量测定。通过在0.075mol/L氨水中用氨基葡萄糖还原0.02mol/L硝酸银来制备银纳米颗粒,并用0.1%聚乙烯吡咯烷酮稳定纳米颗粒,然后将混合物在90℃加热5分钟。制备的分散在水中的银纳米颗粒由于在412nm处有一个局域表面等离子体共振带而呈现亮黄色。氨基葡萄糖传感的原理是基于测量412nm处表面等离子体共振带的强度,该强度与氨基葡萄糖的浓度成正比,线性范围为(1 - 9μg/mL),检测限为0.33μg/mL,定量限为1.0μg/mL。所提出的方法根据国际协调会议(ICH)指南进行了验证,结果表明该方法准确、精密、具有选择性且稳健。该方法采用标准加入法用于测定Joflex®胶囊中的氨基葡萄糖,平均回收率±标准偏差为100.077±1.786。该方法简单、快速且成本效益高,可用于测定原料药及其药物制剂中的氨基葡萄糖。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验